The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.
For the full agenda, visit [ Ссылка ], and for information on the faculty, [ Ссылка ].
In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what treatment is recommended after crizotinib stops working in ROS rearranged lung cancer
A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech
For more, please visit [ Ссылка ]. To join the conversation, visit [ Ссылка ].
![](https://i.ytimg.com/vi/zVZ6QXzkMO4/maxresdefault.jpg)